Robert Zatta - Innophos Holdings Director
Director
Mr. Robert J. Zatta is Independent Director of the Company. He served as the Chief Financial Officer of Rockwood Holdings, Inc., a publiclytraded specialty chemicals company, from March 2001 until January 2015, when Rockwood Holdings, Inc. was acquired by Albemarle Corporationrationration. From July 2014 until January 2015, he also served as the Acting Chief Executive Officer of Rockwood Holdings, Inc. Prior to joining Rockwood, he spent twelve years with the Campbell Soup Company, where he held several significant financial management positions, including his final position as Vice President responsible for Corporationrationrate Development and Strategic Planning. Prior to joining Campbell Soup Company in 1990, he worked for General Foods Corporation and Thomas J. Lipton, Inc. Since March 2017, Mr. Zatta has served as a director of Nexeo Solutions, Inc., a publiclytraded global chemicals and plastics distributor. Since December 2015, Mr. Zatta has served on the Board of Trustees and Chairman of the Audit and Risk Management Committee of Merrimack College since 2016.
| Age | 68 |
| Tenure | 8 years |
| Professional Marks | MBA |
| Phone | 609 495-2495 |
| Web | www.innophos.com |
Innophos Holdings Management Efficiency
Innophos Holdings' management efficiency ratios could be used to measure how well Innophos Holdings manages its routine affairs as well as how well it operates its assets and liabilities.The company currently holds 399.86 M in liabilities with Debt to Equity (D/E) ratio of 118.3, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Innophos Holdings has a current ratio of 2.88, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Innophos Holdings until it has trouble settling it off, either with new capital or with free cash flow. So, Innophos Holdings' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Innophos Holdings sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Innophos to invest in growth at high rates of return. When we think about Innophos Holdings' use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Michael Durham | Herc Holdings | 64 | |
| Mark Behan | Arrow Financial | 57 | |
| Richard Reisman | Arrow Financial | 72 | |
| Robert Wonderling | Univest Pennsylvania | 56 | |
| James Grogan | U Haul Holding | 63 | |
| Jacob Katz | Herc Holdings | 68 | |
| John Murphy | Arrow Financial | 62 | |
| Natalye Paquin | Univest Pennsylvania | 57 | |
| Nicholas Graziano | Herc Holdings | 47 | |
| David Barnes | Herc Holdings | 60 | |
| Margaret Zook | Univest Pennsylvania | 68 | |
| Jay Goldstein | Univest Pennsylvania | 51 | |
| James Acridge | U Haul Holding | 77 | |
| Charles Bayer | U Haul Holding | 76 | |
| Michael Koehler | Herc Holdings | 62 | |
| Elizabeth Little | Arrow Financial | 73 | |
| Douglas Clemens | Univest Pennsylvania | 59 | |
| John Dodds | U Haul Holding | 80 | |
| Jonathan Frates | Herc Holdings | 38 | |
| John Brogan | U Haul Holding | 73 | |
| Sebastien Reyes | U Haul Holding | N/A | |
Management Performance
| Return On Equity | 0.0014 | |||
| Return On Asset | 7.0E-4 |
Innophos Holdings Leadership Team
Elected by the shareholders, the Innophos Holdings' board of directors comprises two types of representatives: Innophos Holdings inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Innophos. The board's role is to monitor Innophos Holdings' management team and ensure that shareholders' interests are well served. Innophos Holdings' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Innophos Holdings' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Randolph Gress, Chairman, CEO and Pres | ||
| Eugenia Erlij, Vice President - Marketing | ||
| Kim Mink, CEO and President and Director | ||
| Abraham Shabot, Vice President Director General, Innophos Latin America | ||
| James Zallie, Independent Director | ||
| Peter Thomas, Director | ||
| Jean Mainente, Chief Human Resource Officer, Senior Vice President | ||
| William Dunworth, Chief Accounting Officer, Vice President Corporate Controller | ||
| Amado Cavazos, Independent Director | ||
| Nicolas Meyrial, Vice President - Commercial Nutrition | ||
| William Farran, Sr. VP, General Counsel and Member of Proxy Committee | ||
| Mark Thurston, Vice President - Corporate Strategy and Worldwide Business Development | ||
| Mark Feuerbach, Sr. VP of Investor Relations, Treasury, Financial Planning and Analysis | ||
| Mark Santangelo, Senior Vice President - Manufacturing, Engineering and EH&S | ||
| Gary Cappeline, Lead Independent Director | ||
| Susan Turner, Vice President - Quality & Regulatory | ||
| Yasef Murat, Senior Vice President - Global Manufacturing | ||
| Hermanus Kieftenbeld, CFO, Senior Vice President | ||
| Linda Myrick, Independent Director | ||
| Amy Hartzell, Vice President - Supply Chain and Purchasing | ||
| Sherry Duff, Chief Marketing Officer, Vice President | ||
| Gail Holler, Vice President - Human Resources | ||
| Joshua Horenstein, Acting Chief Legal Officer and Corporate Secretary | ||
| Jane Hilk, Director | ||
| Louis Calvarin, Chief Risk Officer and Sr. VP of Strategy | ||
| Robert Sklans, Chief Human Resource Officer, Senior Vice President | ||
| Joseph Golowski, Sr. VP of Global Specialty Phosphates | ||
| Charles Brodheim, Vice President Corporate Controller | ||
| Karen Osar, Independent Director | ||
| John Steitz, Independent Director | ||
| Robert Zatta, Director |
Innophos Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Innophos Holdings a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0014 | |||
| Return On Asset | 7.0E-4 | |||
| Profit Margin | 0.0006 % | |||
| Operating Margin | 14.40 % | |||
| Current Valuation | 993.69 M | |||
| Shares Outstanding | 19.69 M | |||
| Shares Owned By Insiders | 1.36 % | |||
| Shares Owned By Institutions | 98.64 % | |||
| Number Of Shares Shorted | 187.27 K | |||
| Price To Earning | 29.65 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. Note that the Innophos Holdings information on this page should be used as a complementary analysis to other Innophos Holdings' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Consideration for investing in Innophos Stock
If you are still planning to invest in Innophos Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Innophos Holdings' history and understand the potential risks before investing.
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |